Volume 12, Number 4, April 2006

Economic Impact of Lyme Disease

Xinzhi Zhang,* Martin I. Meltzer,* César A. Peña,† Annette B. Hopkins,† Lane Wroth,‡ and Alan D. Fix†
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland, Baltimore, Maryland, USA; and ‡Care First-Easton Branch (previously Delmarva Health Plan), Easton, Maryland, USA

Figure 1. Lyme disease (LD) cases reported to the Centers for Disease Control and Prevention by state health departments in the United States (1991–2002). Reported cases were defined according to the national surveillance definition. For the purpose of surveillance, a case of LD is defined as physician-diagnosed erythema migrans >5 cm or >1 late rheumatologic, neurologic, or cardiac manifestation with laboratory evidence of Borrelia burgdorferi infection. Available from http://www.cdc.gov/ncidod/dvbid/lyme/epi.htm (14).

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed March 21, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention